NSC |
Compound |
Enrichment |
Correlation |
NSC 732517 |
Dasatinib |
0.0304779558345021 |
0.0039533388 |
NSC 736079 |
4-[(Z)-2-(5-nitro-thiophen-2-yl)ethenyl]-6-pyrrolidin-1-yl-1 ,3,5-triazin-2-ylamine |
0.0304779558345021 |
0.019602494 |
NSC 740270 |
6-(10'-tert-BOC-aminodecyl)-5,6-dihydro-5,11-dioxo-11H-indeno[1,2-c]isoquinoline |
0.0304779558345021 |
0.10377041 |
NSC 742838 |
7H-Pyrrolo[2,3-d]pyrimidine-5-carboxamide, 4-amino-6-hydrazino-7-.beta.-D-ribofuranosyl-, hydrochloride |
0.0304779558345021 |
-0.0015302672 |
NSC 743244 |
Null |
0.0304779558345021 |
0.39222817 |
NSC 638287 |
Null |
0.0366216145653018 |
0.40167769 |
NSC 668258 |
Null |
0.0366216145653018 |
0.31176643 |
NSC 109451 |
Null |
0.0386895225700407 |
-0.094164763 |
NSC 123461 |
Ethanesulfonic acid, compd. with 4-[[3-[2-chloro-4-(4,6-diamino-2,2-dimethyl-1,3,5-triazin-1(2H)-yl)phenyl]-1-oxopropyl]amino]benzenesulfonyl fluoride (1:1) (9CI) |
0.0386895225700407 |
0.11278491 |
NSC 123463 |
Ethanesulfonic acid, compd. with 4-[3-[p-(4,6-diamino-2,2-dimethyl-s-triazin-1(2H)-yl)benzyl]ureido]-o-toluenesulfonyl fluoride (1:1) (8CI) |
0.0386895225700407 |
0.059285128 |